{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:15:49Z","timestamp":1774458949687,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Colorectal squamous cell carcinoma (CSCC) is an exceedingly rare malignancy, accounting for approximately 0.41% of all colorectal cancers. This case report describes a 52-year-old male with a history of chronic bronchitis, varicose vein of the lower limb, diabetes, and Hepatitis B cirrhosis, who presented with worsening abdominal pain. The patient underwent a right hemicolectomy, and postoperative pathology revealed a moderately differentiated CSCC with proficient mismatch repair (pMMR) status. The patient was initially treated with the CAPEOX adjuvant chemotherapy regimen, the patient\u2019s condition unfortunately progressed. Therefore, the treatment plan has been adjusted to include nab-paclitaxel and carboplatin, in combination with camrelizumab, an Anti-PD-1 therapy, for antitumor therapy. The combination therapy resulted in a partial response. This case highlights the potential efficacy of Anti-PD-1 therapy combined with chemotherapy in CSCC, suggesting a possible treatment approach for this rare cancer subtype.<\/jats:p>","DOI":"10.3389\/fonc.2025.1548008","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:10:42Z","timestamp":1746763842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunotherapy combined with chemotherapy: a promising therapeutic approach in the management of colonic squamous cell carcinoma\u2014a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Bingbing","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12951-024-02701-3","article-title":"Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges","volume":"22","author":"Narayana","year":"2024","journal-title":"J nanobiotechnol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e438466","DOI":"10.1200\/EDBK_438466","article-title":"State-of-the-art management of colorectal cancer: treatment advances and innovation","volume":"44","author":"Pathak","year":"2024","journal-title":"Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v11.12","article-title":"A systematic and comprehensive analysis of colorectal squamous cell carcinoma: Implication for diagnosis and treatment","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10510","article-title":"Primary squamous cell carcinoma of the cecum presenting as spontaneous perforation","volume":"12","author":"Recinos","year":"2020","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-240573","article-title":"Metastatic squamous cell carcinoma of the colon: a conundrum in colorectal Malignancies","volume":"14","author":"Singhal","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2020.0149","article-title":"Primary colonic squamous cell carcinoma: a case report and review of the literature","volume":"102","author":"Linardoutsos","year":"2020","journal-title":"Ann R Coll Surge Engl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-022-01937-w","article-title":"The first comprehensive genomic characterization of rectal squamous cell carcinoma","volume":"58","author":"Astaras","year":"2023","journal-title":"J gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"107383","DOI":"10.1016\/j.ijscr.2022.107383","article-title":"Primary squamous cell carcinoma of the colon: A rare case report","volume":"96","author":"Nassar","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2020.1824044","article-title":"Primary squamous cell carcinoma of colon and rectum: A systematic review of the literature","volume":"35","author":"Schizas","year":"2022","journal-title":"J Invest Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.596342","article-title":"Rectosigmoid-junction squamous cell carcinoma with pMMR\/MSS achieved a partial response following PD-1 blockade combined with chemotherapy: A case report","volume":"11","author":"He","year":"2021","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1265421","article-title":"Case Report: A management strategy and clinical analysis of primary squamous cell carcinoma of the colon","volume":"13","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000303","article-title":"Metastatic cutaneous squamous cell carcinoma of the colon presenting as transfusion-dependent hematochezia","volume":"7","author":"Dornblaser","year":"2020","journal-title":"ACG Case Rep J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2024.05.007","article-title":"Squamous cell carcinoma of the colon: evaluation of treatment modalities and survival","volume":"28","author":"Larkins","year":"2024","journal-title":"J gastrointest Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms","volume":"121","author":"Sahin","year":"2019","journal-title":"Br J Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00762","article-title":"Neoadjuvant immune checkpoint inhibitor therapy for patients with microsatellite instability-high colorectal cancer: shedding light on the future","volume":"19","author":"Sahin","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12876-022-02511-7","article-title":"Efficacy and safety of anti-PD-1\/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis","volume":"22","author":"Li","year":"2022","journal-title":"BMC gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100380","DOI":"10.1016\/j.esmoop.2021.100380","article-title":"Efficacy and activity of PD-1 blockade in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis with focus on the value of PD-L1 combined positive score","volume":"7","author":"Leone","year":"2022","journal-title":"ESMO Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1038\/s41467-023-42900-4","article-title":"Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial","volume":"14","author":"Lim","year":"2023","journal-title":"Nat Commun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1548008\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:10:43Z","timestamp":1746763843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1548008\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":19,"alternative-id":["10.3389\/fonc.2025.1548008"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1548008","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1548008"}}